Regulatory note: Black seed oil carries no authorised health claims under UK or EU regulations. This article describes published research and our formulation — not therapeutic claims. See our standardisation guide for more context.
Why researchers are interested in Nigella sativa
Nigella sativa has a long history of traditional use across the Middle East, South Asia and North Africa — uses that have been documented for over two millennia. That history prompted modern pharmacological interest, and Nigella sativa now has an unusually large body of laboratory research for a food plant: thousands of published studies covering its phytochemistry, the properties of thymoquinone and other constituents, and their effects in cell culture and animal models.[1]
What the laboratory research shows
In laboratory models, thymoquinone has been studied for a wide range of biological activities. These studies are valuable for understanding mechanisms but are not evidence of human benefit — they tell researchers what pathways are worth investigating in humans, not what a supplement will do for the person taking it. This distinction matters, and it is frequently glossed over in supplement marketing. Dozens of compounds show interesting properties in lab models that do not translate to human benefit at the doses achievable through supplementation.
The human trial landscape
Human clinical trials are the evidence standard that matters, and the picture here is more limited. Trials have explored Nigella sativa in relation to various physiological parameters including cardiometabolic markers, weight and immune parameters. A 2023 randomised, double-blind, placebo-controlled trial in 52 healthy young volunteers examined the effect of Nigella sativa on immunity-related parameters and general health markers over three months.[2] This is the type of controlled evidence the field needs more of — and the volume of such trials is growing, though it remains smaller than for more established supplements.
What “a growing body of evidence” actually means
You will often see this phrase used to suggest more certainty than the evidence supports. A body of evidence grows from laboratory studies through to animal models and eventually into human trials — and each step involves attrition: many mechanisms seen in cells do not survive into animals, and many animal effects do not replicate in humans. The Nigella sativa literature is rich in the early phases of this pipeline, and is developing at the clinical end. That is different from an established, replicated clinical evidence base. We say this not to discourage interest but to give you an accurate map of where the science actually stands.[3]
The regulatory position, plainly stated
Under UK law (the retained equivalent of EU Regulation 1924/2006), a health claim may only be made on a food supplement if it is on the authorised GB NHC Register. Black seed oil and thymoquinone are not on that register. This means no claim that it “supports immunity”, “reduces inflammation” or “promotes health” is lawful on a UK supplement. Brands that make such claims are either unaware of or not complying with the rules. We describe only what is in the bottle and how it is made.